Johnson Matthey PLC (LON:JMAT - Get Free Report) insider Richard Pike purchased 17,635 shares of Johnson Matthey stock in a transaction dated Friday, September 11th. The stock was bought at an average price of GBX 2,248 per share, with a total value of £396,434.80.
Richard Pike also recently made the following trade(s):
- On Friday, July 10th, Richard Pike purchased 12 shares of Johnson Matthey stock. The stock was purchased at an average price of GBX 1,909 per share, with a total value of £229.08.
Johnson Matthey Price Performance
LON JMAT traded down GBX 2.13 during trading hours on Friday, reaching GBX 2,245.87. The company's stock had a trading volume of 9,612,290 shares, compared to its average volume of 2,058,961. Johnson Matthey PLC has a 1 year low of GBX 2,218 and a 1 year high of GBX 3,245.33. The company has a quick ratio of 0.76, a current ratio of 1.56 and a debt-to-equity ratio of 69.69. The company has a market capitalization of £2.83 billion, a price-to-earnings ratio of -29.45, a PEG ratio of 49,242.50 and a beta of 0.94. The firm's 50-day moving average price is GBX 2,106.64 and its 200-day moving average price is GBX 2,053.58.
Wall Street Analyst Weigh In
Several research analysts have commented on JMAT shares. Jefferies Financial Group reissued a "buy" rating and set a GBX 2,330 price objective on shares of Johnson Matthey in a report on Tuesday, August 4th. UBS Group reissued a "neutral" rating and set a GBX 2,200 price target on shares of Johnson Matthey in a research note on Friday, May 22nd. Berenberg Bank raised their price target on Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a "buy" rating in a report on Monday, June 1st. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a GBX 2,400 price objective on shares of Johnson Matthey in a research note on Monday, July 6th. Four analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of GBX 2,283.33.
Read Our Latest Stock Analysis on JMAT
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.